Update as of 06 November 2024 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Dapivirine Vaginal Ring, Donepezil Hydrochloride, Tenofovir/Lamivudine/Dolutegravir and Tenofovir + Lamivudine in combination with Dolutegravir ended on 05 November 2024 without appeals received, this preliminary HTA Council recommendation lapsed into the Final Recommendation and was transmitted to the Secretary of continue reading : HTA Council Preliminary Recommendation on Dapivirine Vaginal Ring, Donepezil Hydrochloride, Tenofovir/Lamivudine/Dolutegravir and Tenofovir + Lamivudine in combination with Dolutegravir
HTA Council Preliminary Recommendation on Citicoline For Ischemic Stroke
Update as of 10 October 2024 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Citicoline for Ischemic Stroke ended on 09 October 2024 without appeals received, this preliminary HTA Council recommendation lapsed into the Final Recommendation and was transmitted to the Secretary of Health for decision. Published 25 continue reading : HTA Council Preliminary Recommendation on Citicoline For Ischemic Stroke
HTA Council Preliminary Recommendation on Pneumococcal Conjugate Vaccines (PCV) for infants less than 1 year old and children aged 13 to 23 months for catch-up immunization
Update as of 10 October 2024 : The public consultation and appeals period for the HTA Council Preliminary Recommendation on Pneumococcal Conjugate Vaccines (PCV) for infants less than 1 year old and children aged 13 to 23 months for catch-up immunization ended on 09 October 2024. Since there were valid appeals received, re-evaluation is currently continue reading : HTA Council Preliminary Recommendation on Pneumococcal Conjugate Vaccines (PCV) for infants less than 1 year old and children aged 13 to 23 months for catch-up immunization
HTA Council Recommendation on Calcium Hydroxide 80% + Clinoptilolite 20% (Kiti-kitiX) Larvicide
As per the Department of Health (DOH) Department Circular 2024 -0308 published 31 July 2024, the Secretary of Health (SOH) fully concurs with the HTA Council recommendation on the non-financing and non-inclusion of Calcium Hydroxide 80% + Clinoptilolite 20% (Kiti-kitiX) Larvicide in the list of larvicides to be used by the Aedes Borne Viral Diseases continue reading : HTA Council Recommendation on Calcium Hydroxide 80% + Clinoptilolite 20% (Kiti-kitiX) Larvicide
[Advisory] Release of HTA Topic Prioritization List 2024 – Cycle 2 Topics that will proceed to Topic Assessment
Following the stakeholder consultation (23 April 2024), appeals period (12 April to 10 May 2024) on the provisional HTA Topic Prioritization List 2024 – Cycle 2 Topics, and processing of 41 appeals, the HTA Council hereby makes public the FINAL HTA Topic Prioritization List 2024 – Cycle 2 Topics. These prioritized topics will now be continue reading : [Advisory] Release of HTA Topic Prioritization List 2024 – Cycle 2 Topics that will proceed to Topic Assessment